NextCure, Inc.

NASDAQ:NXTC

0.8225 (USD) • At close January 3, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Omzet 0006.2840000000000000022.3782.0051.5831.4021.3570000
Kosten van de omzet 00.7010.940.8240.9461.0861.1101.02102.0972.1032.0961.8921.10512.10612.7411.1310.57811.3978.6637.6436.5136.314.8544.4344.21
Brutowinst 0-0.701-0.945.46-0.946-1.086-1.110-1.0210-2.097-2.103-2.096-1.892-1.105-12.106-12.74-11.1311.8-9.392-7.08-6.241-5.156-6.31-4.854-4.434-4.21
Brutowinstmarge 0000.86900000000000-540,977,745,999.536000.527-4.684-4.473-4.451-3.80000
Onderzoek- en ontwikkelingskosten 8.7712.41811.39811.82711.0113.44711.64712.82213.52812.82515.02412.26413.59711.94512.38612.10612.7411.1310.57811.3978.6637.6436.5136.2484.8954.4344.21
Algemene en administratieve kosten 3.7254.0764.3643.9634.6085.7115.4244.9495.7115.3035.7474.8074.9116.0074.8484.1314.6594.6713.5882.6182.6222.7141.6590.8190.9250.8660.799
Verkoop- en marketingkosten 0-0.7013.42-0.82400000000000000000000000
Verkoop-, algemene en administratieve kosten 3.7253.3753.4243.1394.6085.7115.4244.9495.7115.3035.7474.8074.9116.0074.8484.1314.6594.6713.5882.6182.6222.7141.6590.8190.9250.8660.799
Overige kosten 01.091.1971.3231.3171.2990.97500.3280.2080.1690.1320.578-0.0350.7010.7761.0321.2931.5211.0831.2680.7340.660.2050.110.0690.013
Bedrijfskosten 12.49515.79314.82214.96615.61819.15817.07117.77119.23918.12820.77117.07118.50817.95217.23416.23717.39915.80114.16614.01511.28510.3578.1727.0675.825.35.009
Bedrijfsresultaat -12.495-16.494-15.762-15.79-15.618-19.158-17.071-17.771-19.239-18.128-20.771-17.071-18.508-17.952-17.234-16.237-17.399-15.801-8.212-12.01-9.702-8.955-6.815-7.067-5.82-5.3-5.009
Bedrijfsresultaat ratio 000-2.51300000000000-725,578,693,359.5500-0.367-5.99-6.129-6.387-5.0220000
Totaal overige inkomsten en kosten netto 0.9551.09-1.3451.3231.3171.2990.9750.4710.3280.2080.1690.1320.578-0.0350.7010.7761.0321.2931.5211.0831.2680.7340.660.2050.110.0690.013
Inkomen voor belasting -11.54-15.404-17.107-14.467-14.301-17.859-16.096-17.3-18.911-17.92-20.602-16.939-17.93-17.987-16.533-15.461-16.367-14.5089.733-10.927-8.434-8.221-6.155-6.862-5.71-5.231-4.996
Inkomen voor belasting ratio 000-2.30200000000000-690,901,778,532.487000.435-5.45-5.328-5.864-4.5360000
Belastingkosten 000.8970.9750.9860.832-0.9750-0.328-0.207-0.1690000000000000000
Nettowinst -11.54-15.404-17.107-14.467-14.301-17.859-15.121-17.3-18.583-17.713-20.433-16.939-17.93-17.987-16.533-15.461-16.367-14.5089.733-10.927-8.434-8.221-6.155-6.862-5.71-5.231-4.996
Nettowinstmarge 000-2.30200000000000-690,901,778,532.487000.435-5.45-5.328-5.864-4.5360000
WPA (Winst Per Aandeel) -0.41-0.55-0.61-0.52-0.51-0.64-0.540-0.67-0.64-0.74-0.61-0.65-0.65-0.6-0.56-0.59-0.530.35-0.4-0.37-0.61-0.28-0.68-0.57-0.52-0.5
Verwaterde WPA -0.41-0.55-0.61-0.52-0.51-0.64-0.540-0.67-0.64-0.74-0.61-0.65-0.65-0.6-0.56-0.59-0.530.33-0.4-0.37-0.61-0.28-0.68-0.57-0.52-0.5
EBITDA -11.795-15.793-14.972-14.966-14.672-18.204-16.111-16.764-18.218-17.09-19.713-14.836-16.766-17.663-16.129-15.247-16.514-15.0148.963-11.255-8.914-8.373-6.252-6.549-5.424-4.913-4.633
EBITDA ratio 000-2.38200000000000-681,338,814,907.499000.401-5.613-5.631-5.972-4.6070000